Mycophenolate mofetil (MMF)/tacrolimus (FK506) is an effective and safe regimen for graft versus host disease (GVHD) prophylaxis in pediatric allogeneic stem cell transplant (AlloSCT) recipients: Altered MMF pharmacokinetics (PK) and association with acute GVHD

被引：0
|
作者：
Osunkwo, I [1 ]
Bessmertny, O [1 ]
Harrison, L [1 ]
Garvin, J [1 ]
George, D [1 ]
Bradley, MB [1 ]
DelToro, G [1 ]
Wischhover, C [1 ]
Wolownik, K [1 ]
van de Ven, C [1 ]
Cheung, YK [1 ]
Cairo, MS [1 ]
机构：
[1] Columbia Univ, New York, NY 10027 USA
来源：
PEDIATRIC RESEARCH | 2003年 / 53卷 / 04期
关键词：
D O I：
暂无
中图分类号：
R72 [儿科学];
学科分类号：
100202 ;
摘要：
2988
引用
收藏
页码：528A / 528A
页数：1
相关论文
共 50 条
  • [41] WHERE TO BIOPSY IN THE GASTROINTESTINAL (GI) TRACT TO DIAGNOSE ACUTE GRAFT VERSUS HOST DISEASE (AGVHD) IN PEDIATRIC ALLOGENEIC STEM CELL TRANSPLANT RECIPIENTS (AlloSCT)
    Martinez, M.
    Billore, G.
    Desai, M.
    Chu, K.
    Remotti, H.
    Satwani, P.
    Cairo, I. S.
    DeFelice, A.
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2008, 14 (02) : 132 - 132
  • [42] Macrophage migratory inhibitory factor (MIF) expression in acute graft-versus-host disease (GVHD) in allogeneic hemopoietic stem cell transplant recipients
    JWS Lo
    AYH Leung
    XR Huang
    AKW Lie
    C Metz
    R Bucala
    R Liang
    HY Lan
    Bone Marrow Transplantation, 2002, 30 : 375 - 380
  • [43] Macrophage migratory inhibitory factor (MIF) expression in acute graft-versus-host disease (GVHD) in allogeneic hemopoietic stem cell transplant recipients
    Lo, JWS
    Leung, AYH
    Huang, XR
    Lie, AKW
    Metz, C
    Bucala, R
    Liang, R
    Lan, HY
    BONE MARROW TRANSPLANTATION, 2002, 30 (06) : 375 - 380
  • [44] Time in therapeutic range of tacrolimus in allogeneic hematopoietic stem cell transplant recipients is associated with acute graft-versus-host disease prophylaxis
    Yoshikawa, Naoki
    Ehara, Yukina
    Yamada, Yusei
    Matsusaki, Yuki
    Shimoda, Kazuya
    Ikeda, Ryuji
    SCIENTIFIC REPORTS, 2025, 15 (01):
  • [45] Mycophenolate mofetil administered every 8 hours in combination with tacrolimus is efficacious in the prophylaxis of acute graft versus host disease in childhood, adolescent, and young adult allogeneic stem cell transplantation recipients
    Militano, Olga
    Ozkaynak, Mehmet F.
    Mehta, Brinda
    van deVen, Carmella
    Hamby, Carl
    Cairo, Mitchell S.
    PEDIATRIC BLOOD & CANCER, 2018, 65 (08)
  • [46] A Pharmacokinetic and Pharmacodynamic Study of Maraviroc as Acute Graft-versus-Host Disease Prophylaxis in Pediatric Allogeneic Stem Cell Transplant Recipients with Nonmalignant Diagnoses
    Khandelwal, Pooja
    Fukuda, Tsuyoshi
    Mizuno, Kana
    Teusink-Cross, Ashley
    Mehta, Parinda A.
    Marsh, Rebecca A.
    Kashuba, Angela D. M.
    Vinks, Alexander A.
    Davies, Stella M.
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2016, 22 (10) : 1829 - 1835
  • [47] Intensified Mycophenolate Mofetil (MMF) Dosing Every 8 Hours Is Safe From The Standpoint Of Engraftment and May Ameliorate Severe Acute Graft-Versus-Host Disease (GVHD) After Double-Unit Cord Blood Transplantation (CBT)
    Ponce, Doris M.
    Harnicar, Stephen J.
    Devlin, Sean
    Hilden, Patrick
    Evans, Katherine L.
    Lubin, Marissa N.
    Giralt, Sergio A.
    Goldberg, Jenna D.
    Perales, Miguel-Angel
    Kernan, Nancy A.
    Prockop, Susan E.
    Scaradavou, Andromachi
    Barker, Juliet N.
    BLOOD, 2013, 122 (21) : 4600 - 4602
  • [48] Post-Transplant Cyclophosphamide (PTCy) Based Graft Versus Host Disease (GVHD) Prophylaxis is Safe and Effective in Elderly Patients over Age 70 Years Undergoing Allogeneic (Allo) Stem Cell Transplantation (SCT)
    Nath, Rajneesh
    Kodali, Murali
    Kamal, Ashan
    Ulrickson, Matthew
    Go, Aileen
    Madan, Sumit
    Heers, Haley
    De Padova, Nicholas
    Miller, Richelle
    Mohammed, Reeshma
    Yasuda, Rachel
    Pebler, Haley
    Zhou, Zheng
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2023, 23 : S537 - S538
  • [49] Acute graft versus host disease (GVHD) is increased in patients receiving cyclosporine/celicept as frontline prophylaxis against GVKD in pediatric patients undergoing allogeneic stem cell transplantation.
    Lakshminarayanan, Sonali
    Szabolcs, Paul
    Prasad, Vinod
    Parikh, Suhag
    Wood, Susan
    Ciocci, Gilbert
    Stafford, Lauren
    Boyd, Lynn
    Driscoll, Timothy
    Martin, Paul L.
    Kurtzberg, Joanne
    BLOOD, 2006, 108 (11) : 820A - 820A
  • [50] Posaconazole (POS) vs fluconazole (FLU) for prophylaxis of invasive fungal infections (IFIs) in allogeneic hematopoietic stem cell transplant (HSCT) recipients with graft-versus-host disease (GVHD): A multicenter trial
    Durrant, S
    Vesole, D
    Langston, A
    Lipton, JH
    Patino, H
    Pedicone, L
    Ullmann, AJ
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2006, 12 (02) : 134 - 134
12345